The tumor doubling time was 3.6 days (control siRNA) and 6.6 days (ABCG2 siRNA), and the tumor inhibition rate on day 22 was 64.8% for the group treated with ABCG2 siRNA. This evidence concerns the gene ABCG2 and neoplasm.